BioSig executes agreement with Bellin for acquisition of PURE EP technology

BioSig Technologies announced that Bellin Health System in Green Bay, Wisconsin has signed an agreement to acquire the Company’s PURE EP System. The agreement follows a 60-day formal evaluation of the PURE EP System at Bellin Health. The hospital reported that the PURE EP demonstrated a significant cost savings per case as well as a substantial reduction in noise and signal interference compared to the use of conventional systems only. The agreement grants Bellin Health full autonomy with respect to its operation of the PURE EP System, and BioSig will not be required to provide an on-site clinical account manager following the new system install. "Bellin has observed, first-hand, that clear cardiac signals provide more information that can impact procedural efficiency without driving up procedural costs," commented Gray Fleming, Chief Commercial Officer, BioSig Technologies. "The terms of this agreement represent a new milestone for the PURE EP(TM) System-expanding the accessibility and automaticity of our novel digital signal processing technology."